The evolution of lung cancer and impact of subclonal selection in tracerx

HIGHLIGHTS

• who: Alexander M. Frankell from the Prospective recruitment of , patients into TRACERx The TRACERx , cohort represents the first , patients prospectively recruited across , hospital sites in the United KingdomRecruitment conformed to a study protocol, implemented and monitored by the Cancer Research UK and University College London Cancer Trials Centre (Fig. , and Supplementary Table, ). Recruitment was broadly representative of an early-stage operable NSCLC population in the United Kingdom according to ethnicity, age, sex and smoking status. The cohort consisted of , males and , females, with a median age of , years (range of, years), and , patients with stage I disease . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.